|
Categories
Pharmaceutical Company Pharmaceutical Sales Pharmaceutical
Distributor Pharmaceutical
Preparation Pharmaceutical
Jobs Pharmaceutical
Industry Pharmaceutical
Drug Pharmaceutical
Sales Jobs Pharmaceutical
Product Pharmaceutical
News Pharmaceutical
Research Pharmaceutical
Manufacturer Pharmaceutical Sales
Rep Pharmaceutical
Sales Resume Pharmaceutical
Online Pharmaceutical
Marketing Pharmaceutical
Dictionary Pharmaceutical
Recruiter Pharmaceutical
Supply Pharmaceutical
Technology Pharmaceutical
Advertising Pharmaceutical
Schools
Companies
Pfizer Pharmaceutical Wyeth Pharmaceutical Watson Pharmaceutical Merck Pharmaceutical Roche Pharmaceutical King Pharmaceutical Teva Pharmaceutical Aventis
Pharmaceutical Novartis
Pharmaceutical Forest
Pharmaceutical Tap
Pharmaceutical Shire
Pharmaceutical Mayne
Pharmaceutical Millennium
Pharmaceutical Lilly
Pharmaceutical Mylan
Pharmaceutical Kos
Pharmaceutical Takeda
Pharmaceutical Endo
Pharmaceutical Janssen
Pharmaceutical Barr
Pharmaceutical Abbott
Pharmaceutical Reliant
Pharmaceutical Solvay
Pharmaceutical Amylin
Pharmaceutical Vertex
Pharmaceutical Osi
Pharmaceutical Bayer
Pharmaceutical Voyager
Pharmaceutical Mcneil
Pharmaceutical Boehringer
Ingelheim Astra
Zeneca Pharmaceutical Glaxosmithkline
Pharmaceutical Novo Nordisk
Pharmaceutical 3m
Pharmaceutical Eli
Lilly Pharmaceutical Elan Pharmaceutical Ivax
Pharmaceutical
Search engines:
Google
Lycos
AltaVista
Yahoo
Mirago
Ask
Teoma
Excite |
|
|
|
Home /
Eli Lilly Pharmaceutical
Eli Lilly Pharmaceutical
Eli Lilly Pharmaceutical
Eli Lilly and Company Limited is the UK
affiliate of major American pharmaceutical manufacturer, Eli Lilly and Company
of Indianapolis. This affiliate is one of the UK's top pharmaceutical
companies, with a research and development centre, two manufacturing sites and
a distribution centre which exports medicines to all parts of the
world.
Lilly medicines treat schizophrenia, diabetes, cancer,
osteoporosis, attention deficit hyperactivity disorder, erectile dysfunction,
severe sepsis, depression, infections, bipolar disorder and many other
diseases.
Eli Lilly and Company is one of the world's largest research
based pharmaceutical companies dedicated to creating and delivering innovative
pharmaceutical health care solutions that enable people to live longer,
healthier and more active lives.
Eli Lilly research and development
efforts constantly strive to address urgent, unmet medical needs and to replace
more expensive and invasive medical treatments. As Eli Lilly pursue this goal
we endeavour to reduce the cost of disease thereby creating significant value
to health care providers and in turn benefits to patients.
Lilly employs
more than 44,000 people world-wide and markets its products in 143
countries.
The UK has a proud history of medical discovery and the Lilly
Research & Development facility at Erl Wood Manor, Windlesham, Surrey
continues this tradition. The Lilly Research Centre founded in 1967 has served
as a centre of excellence contributing to the development of much needed new
medicines. The most recent breakthrough was in the discovery and development of
an innovative and very successful treatment for schizophrenia. This medicine is
already a huge success for patients across the world. More recently this site
won Lilly the "Queen's Award for Innovation" for the discovery and
commercialisation of Zyprexa®.
Multidisciplinary development teams
are dedicated to meeting unmet medical needs across a range of specialist
therapeutic areas including disorders of the central nervous system, diabetes
and cancer.
Lilly UK - Sales & Marketing
Lilly UK is one of the largest providers of
medicines to the UK National Health Service. Lilly's medicines are currently
treating schizophrenia, diabetes, bipolar disorder, stress urinary
incontinence, erectile dysfunction, depression, cancer, heart disease, pain,
infections and gastric disorders across the UK and bringing relief to millions
of people.
Headquartered in Basingstoke, Hampshire with employees
throughout England, Scotland, Wales and Northern Ireland the company is
committed to creating value adding relationships throughout the NHS. This
relationship is not simply about selling medicines it is all about adding value
to the health care delivery process for the optimum benefit of the patient and
the health care professional.
Lilly's continuing success is based upon
working in partnership with health care professionals, listening to patients
and responding quickly to changing circumstances. The company believes that the
prevention and treatment of disease is about much more than providing effective
medicines. That is why Lilly takes a lead in providing a wide range of support
services such as health outcome data, specialist product services, information
packs, and non product related services such as business management training.
The National Health Service is constantly changing and Lilly has been
at the forefront of adapting to its changing customer's needs. The company
works closely with NHS managers on best practice in health management,
optimising health outcomes and assisting in effective clinical management to
ensure that the best possible value can be derived from the company's
medicines.
Discovering and delivering innovative ground breaking
medicines to the patient is an expensive and lengthy process - more than
£300 million and 10 years for each new medicine. However modern medicines
often reduce the cost of disease to society as a whole. The introduction of
anti-ulcer drugs in the 'eighties almost totally eradicated the need for
expensive surgery. The advent of effective medicines for HIV has meant the
closure of hospital wards and subsequent economic savings. Of course Lilly does
not believe such claims should be taken at face value and invests in health
economic evaluative research to demonstrate the true value of its innovative
medicines.
Latest Eli Lilly pharmaceutical news
Job fair simplifies the search for work. N.H. gets tough on drug manufacturers. more speechwriting tips from Friedman.. Enterprise Integration Is One of Six Tracks Featured at Upcoming ISA Expo. The ED Conversation Dilemma: Forty Percent Of Men With ED Don't Talk To Their Doctor, Survey Finds. July 16: Isa Expo Offers Technical Conference Track, Exhibit Floor.... CMC Icos Biologics has big plans for former Icos plant in Bothell. Will Lilly's Survey Have the Desired Effect on Cialis?. Eli Lilly and the Surviving Sepsis Guidelines. Folo: Global Counsel Awards Announced. Eli Lilly: Good Dividend but Is the Stock Worth the Risk?. Big Pharma Gets Enlightened. Pfizer, Merck and Lilly Partner to Get "Enlightened". Lilly Targets a Tiny Prize. New England Cuts 2008 Plant Closures 30% Over Last Year, an Industrial Info News Alert. Lilly, Merck and Pfizer form research venture. Eli Lilly and Company Pays Entelos, Inc. for Perpetual License. Informatics professor receives $120,000 grant from Eli Lilly & Co.. Why Is The Zyprexa Judge Smiling? // Pharmalot. Eli Lilly Zyprexa Diabetes link. read more
Eli Lilly further information: www.lilly.co.uk /
www.lilly.com/ / Eli
Lilly news
Page last updated: 11/06/08 |
|
|
|
|